Because physical exercise increases demand on a weakened heart, measures of exercise tolerance are frequently used to monitor the severity of heart failure
Therefore, many individuals with type 2 diabetes have a residual risk for cardiovascular disease, despite receiving the recommended therapies for dyslipidaemia and hyperglycaemia
New research reveals how GLP-1 medications are reshaping the treatment landscape for conditions affecting the heart, kidney, liver, and more, hinting at a new era in chronic disease management
After final alkylation, all samples were diluted (1:1) with 20% ACN/0.1% FA containing 50 nM of deuterated internal standards and analyzed by LC-MS
Could BPC-157 Support Knee Recovery
Frequently Asked Questions About Peptide Therapy 1